Signal transduction in DC differentiation: Winged messengers and Achilles' heel

Advances in Experimental Medicine and Biology

Volumn 590, Issue , 2007, Pages 1-29

  Lindner, Inna ^a   Cejas, Pedro J ^a   Carlson, Louise M ^a   Torruellas, Julie ^a   Plano, Gregory V ^a   Lee, Kelvin P ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; TRANSCRIPTION FACTOR RELB;

ACHILLES TENDON; CELL DIFFERENTIATION; CELL DISRUPTION; CELL FUNCTION; CONFERENCE PAPER; DENDRITIC CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STIMULUS; YERSINIA ENTEROCOLITICA; YERSINIA PSEUDOTUBERCULOSIS;

EID: 84934436108     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-34814-8_1     Document Type: Conference Paper

References (170)

1. J. Sprent, H. Kishimoto. The thymus and negative selection. Immunol Rev 185:126-135 (2002).
2. D. Mathis and C. Benoist. Back to central tolerance. Immunity 20(5):509-516 (2004).
3. J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran and K. Palucka. Immunobiology of dendritic cells. Annu Rev Immunol 18(4):767-811 (2000).
4. J. Banchereau and R.M. Steinman. Dendritic cells and the control of immunity. Nature 392(6673):245-252 (1998).
5. M. Rescigno, C. Winzler, D. Delia, C. Mutini, M. Lutz and P. Ricciardi-Castagnoli. Dendritic cell maturation is required for initiation of the immune response. J Leukoc Biol 61(4):415-421 (1997).
6. P. Matzinger. Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045 (1994).
7. C. Winzler, P. Rovere, M. Rescigno, F. Granucci, G. Penna, L. Adorini, V.S. Zimmermann, J. Davoust and P. Ricciardi-Castagnoli. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 185(2):317-328 (1997).
8. E.C. de Jong, H.H. Smits and M.L. Kapsenberg. Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol 26(3):289-307 (2005).
9. K.M. Murphy, W. Ouyang, J.D. Farrar, J. Yang, S. Ranganath, H. Asnagli, M. Afkarian and T.L. Murphy. Signaling and transcription in T helper development. Annu Rev Immunol 18:451-494 (2000).
10. M. Moser and K.M. Murphy. Dendritic cell regulation of TH1-TH2 development. Nat Immunol 1(3):199-205 (2000).
11. A. D'Andrea, X. Ma, M. Aste-Amezaga, C. Paganin and G. Trinchieri. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med 181(2):537-546 (1995).
12. C. Heufler, F. Koch, U. Stanzl, G. Topar, M. Wysocka, G. Trinchieri, A. Enk, R.M. Steinman, N. Romani and G. Schuler. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 26(3):659-668 (1996).
13. F. Koch, U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani and G. Schuler. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 184(2):741-746 (1996).
14. M. Croft, D.D. Duncan and S.L. Swain. Response of naive antigen-specific CD4+ T cells in vitro: characteristics and antigen-presenting cell requirements. J Exp Med 176(5):1431-1437 (1992).
15. S.E. Macatonia, C.S. Hsieh, K.M. Murphy and A. O'Garra. Dendritic cells and macrophages are required for Th1 development of CD4+ T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-gamma production is IFN-gamma-dependent. Int Immunol 5(9):1119-1128 (1993).
16. A.H. Enk. Dendritic cells in tolerance induction. Immunol Lett 99(1):8-11 (2005).
17. M.V. Dhodapkar, R.M. Steinman, J. Krasovsky, C. Munz and N. Bhardwaj. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193(2):233-238 (2001).
18. M.B. Lutz, R.M. Suri, M. Niimi, A.L. Ogilvie, N.A. Kukutsch, S. Rossner, G. Schuler and J.M. Austyn. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 30(7):1813-1822 (2000).
19. H. Jonuleit, E. Schmitt, G. Schuler, J. Knop and A.H. Enk. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192(9):1213-1222 (2000).
20. K. Steinbrink, M. Wolfl, H. Jonuleit, J. Knop and A.H. Enk. Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159(10):4772-4780 (1997).
21. L. Piemonti, P. Monti, P. Allavena, M. Sironi, L. Soldini, B.E. Leone, C. Socci and V. Di Carlo. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 162(11):6473-6481 (1999).
22. L. Piemonti, P. Monti, M. Sironi, P. Fraticelli, B.E. Leone, E. Dal Cin, P. Allavena and V. Di Carlo. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 164(9):4443-4451 (2000).
23. P. Kalinski, C.M. Hilkens, A. Snijders, F.G. Snijdewint and M.L. Kapsenberg. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol 159(1):28-35 (1997).
24. A.H. Enk, H. Jonuleit, J. Saloga and J. Knop. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer 73(3):309-316 (1997).
25. C. Rastellini, L. Lu, C. Ricordi, T.E. Starzl, A.S. Rao and A.W. Thomson. Granulocyte/ macrophage colony-stimulating factor-stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 60(11):1366-1370 (1995).
26. E. Martin, B. O'Sullivan, P. Low and R. Thomas. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 18(1):155-167 (2003).
27. A.G. Thompson, B.J. O'Sullivan, H. Beamish and R. Thomas. T cells signaled by NF-kappa B- dendritic cells are sensitized not anergic to subsequent activation. J Immunol 173(3):1671-1680 (2004).
28. D. Gabrilovich, T. Ishida, T. Oyama, S. Ran, V. Kravtsov, S. Nadaf and D.P. Carbone. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92(11):4150-4166 (1998).
29. K. Shortman and Y.J. Liu. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2(3):151-161 (2002).
30. Q. Huang, D. Liu, P. Majewski, L.C. Schulte, J.M. Korn, R.A. Young, E.S. Lander and N. Hacohen. The plasticity of dendritic cell responses to pathogens and their components. Science 294(5543):870-875 (2001).
31. Y.J. Liu. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106(3):259-262 (2001).
32. R. Maldonado-Lopez, T. De Smedt, P. Michel, J. Godfroid, B. Pajak, C. Heirman, K. Thielemans, O. Leo, J. Urbain and M. Moser. CD8alpha+ and CD8alpha- sub-classes of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 189(3):587-592 (1999).
33. B. Pulendran, J.L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky and C.R. Maliszewski. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 96(3):1036-1041 (1999).
34. I. Szatmari, P. Gogolak, J.S. Im, B. Dezso, E. Rajnavolgyi and L. Nagy. Activation of PPARgamma specifies a dendritic cell subtype capable of enhanced induction of iNKT cell expansion. Immunity 21(1):95-106 (2004).
35. P. Cheng, Y. Nefedova, L. Miele, B.A. Osborne and D. Gabrilovich. Notch signaling is necessary but not sufficient for differentiation of dendritic cells. Blood 102(12):3980-3988 (2003).
36. K.L. Anderson, H. Perkin, C.D. Surh, S. Venturini, R.A. Maki and B.E. Torbett. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J Immunol 164(4):1855-1861 (2000).
37. B. Almand, J.I. Clark, E. Nikitina, J. van Beynen, N.R. English, S.C. Knight, D.P. Carbone and D.I. Gabrilovich. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 166(1):678-689 (2001).
38. C. Caux, C. Dezutter-Dambuyant, D. Schmitt and J. Banchereau. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360(6401):258-261 (1992).
39. T.A. Davis, A.A. Saini, P.J. Blair, B.L. Levine, N. Craighead, D.M. Harlan, C.H. June and K.P. Lee, Phorbol esters induce differentiation of human CD34+ hemopoietic progenitors to dendritic cells: evidence for protein kinase C-mediated signaling. J Immunol 160(8):3689-3697 (1998).
40. R.E. Ryncarz and C. Anasetti. Expression of CD86 on human marrow CD34(+) cells identifies immunocompetent committed precursors of macrophages and dendritic cells. Blood 91(10):3892-3900 (1998).
41. M.G. Manz, D. Traver, K. Akashi, M. Merad, T. Miyamoto, E.G. Engleman and I.L. Weissman. Dendritic cell development from common myeloid progenitors. Ann NY Acad Sci 938(167-173; discussion 173-164) (2001).
42. M.G. Manz, D. Traver, T. Miyamoto, I.L. Weissman and K. Akashi. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 97(11):3333-3341 (2001).
43. J.W. Young, P. Szabolcs and M.A. Moore. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med 182(4):1111-1119 (1995).
44. S.M. Kiertscher and M.D. Roth. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J Leukoc Biol 59(2):208-218 (1996).
45. L.J. Zhou and T.F. Tedder. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 93(6):2588-2592 (1996).
46. L. Oehler, O. Majdic, W.F. Pickl, J. Stockl, E. Riedl, J. Drach, K. Rappersberger, K. Geissler and W. Knapp. Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. J Exp Med 187(7):1019-1028 (1998).
47. B.C. Hulette, G. Rowden, C.A. Ryan, C.M. Lawson, S.M. Dawes, G.M. Ridder and G.F. Gerberick. Cytokine induction of a human acute myelogenous leukemia cell line (KG-1) to a CD1a+ dendritic cell phenotype. Arch Dermatol Res 293(3):147-158 (2001).
48. A. Cignetti, E. Bryant, B. Allione, A. Vitale, R. Foa and M.A. Cheever. CD34(+) acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells. Blood 94(6):2048-2055 (1999).
49. B.A. Choudhury, J.C. Liang, E.K. Thomas, L. Flores-Romo, Q.S. Xie, K. Agusala, S. Sutaria, I. Sinha, R.E. Champlin and D.F. Claxton. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood 93(3):780-786 (1999).
50. A. Charbonnier, B. Gaugler, D. Sainty, M. Lafage-Pochitaloff and D. Olive. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur J Immunol 29(8):2567-2578 (1999).
51. B.D. Harrison, J.A. Adams, M. Briggs, M.L. Brereton and J.A. Yin. Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia. Blood 97(9):2764-2771 (2001).
52. N. Bendriss-Vermare, C. Barthelemy, I. Durand, C. Bruand, C. Dezutter-Dambuyant, N. Moulian, S. Berrih-Aknin, C. Caux, G. Trinchieri and F. Briere. Human thymus contains IFN-alpha-producing CD11c(-), myeloid CD11c(+), and mature interdigitating dendritic cells. J Clin Invest 107(7):835-844 (2001).
53. A. Galy, M. Travis, D. Cen and B. Chen. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3(4):459-473 (1995).
54. F. Sallusto and A. Lanzavecchia. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/ macrophage colonystimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179(4):1109-1118 (1994).
55. M.C. Rissoan, V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. de Waal Malefyt and Y.J. Liu. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283(5405):1183-1186 (1999).
56. G.J. Randolph, S. Beaulieu, S. Lebecque, R.M. Steinman and W.A. Muller. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282(5388):480-483 (1998).
57. G. Grouard, M.C. Rissoan, L. Filgueira, I. Durand, J. Banchereau and Y.J. Liu. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185(6):1101-1111 (1997).
58. C. Caux, C. Massacrier, B. Vanbervliet, B. Dubois, B. de Saint-Vis, C. Dezutter-Dambuyant, C. Jacquet, D. Schmitt and J. Banchereau. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. Adv Exp Med Biol 417(5):21-25 (1997).
59. C. Caux, B. Vanbervliet, C. Massacrier, B. Dubois, C. Dezutter-Dambuyant, D. Schmitt and J. Banchereau. Characterization of human CD34+ derived dendritic/ Langerhans cells (D-Lc). Adv Exp Med Biol 378:1-5 (1995).
60. M. Waclavicek, A. Berer, L. Oehler, J. Stockl, E. Schloegl, O. Majdic and W. Knapp. Calcium ionophore: a single reagent for the differentiation of primary human acute myelogenous leukaemia cells towards dendritic cells. Br J Haematol 114(2):466-473 (2001).
61. B.J. Czerniecki, C. Carter, L. Rivoltini, G.K. Koski, H.I. Kim, D.E. Weng, J.G. Roros, Y.M. Hijazi, S. Xu, S.A. Rosenberg and P.A. Cohen. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol 159(8):3823-3837 (1997).
62. G.K. Koski, G.N. Schwartz, D.E. Weng, B.J. Czerniecki, C. Carter, R.E. Gress and P.A. Cohen. Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. J Immunol 163(1):82-92 (1999).
63. D.C. St Louis, J.B. Woodcock, G. Fransozo, P.J. Blair, L.M. Carlson, M. Murillo, M.R. Wells, A.J. Williams, D.S. Smoot, S. Kaushal, J.L. Grimes, D.M. Harlan, J.P. Chute, C.H. June, U. Siebenlist and K.P. Lee. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model. J Immunol 162(6):3237-3248 (1999).
64. L. Flores-Romo, P. Bjorck, V. Duvert, C. van Kooten, S. Saeland and J. Banchereau. CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells. J Exp Med 185(2):341-349 (1997).
65. L. Oehler, A. Berer, M. Kollars, F. Keil, M. Konig, M. Waclavicek, O. Haas, W. Knapp, K. Lechner and K. Geissler. Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia. Ann Hematol 79(7):355-362 (2000).
66. M. Heinzinger, C.F. Waller, A. von den Berg, A. Rosenstiel and W. Lange. Generation of dendritic cells from patients with chronic myelogenous leukemia. Ann Hematol 78(4):181-186 (1999).
67. D. Vremec and K. Shortman. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J Immunol 159(2):565-573 (1997).
68. E. Maraskovsky, K. Brasel, M. Teepe, E.R. Roux, S.D. Lyman, K. Shortman and H.J. McKenna. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med 184(5):1953-1962 (1996).
69. B. Pulendran, J. Lingappa, M.K. Kennedy, J. Smith, M. Teepe, A. Rudensky, C.R. Maliszewski and E. Maraskovsky. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol 159(5):2222-2231 (1997).
70. A. Curti, M. Fogli, M. Ratta, S. Tura and R.M. Lemoli. Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors. J Immunol 166(2):848-854 (2001).
71. J. Taieb, K. Maruyama, C. Borg, M. Terme and L. Zitvogel, Imatinib mesylate impairs Flt3L-mediated dendritic cell expansion and antitumor effects in vivo. Blood 103(5):1966-1967 [author reply, 1967] (2004).
72. K. Saraya and C.D. Reid. Stem cell factor and the regulation of dendritic cell production from CD34+ progenitors in bone marrow and cord blood. Br J Haematol 93(2):258-264 (1996).
73. S. Akira, K. Takeda and T. Kaisho. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2(8):675-680 (2001).
74. G.M. Zou and Y.K. Tam, Cytokines in the generation and maturation of dendritic cells: recent advances. Eur Cytokine Network 13(2):186-199 (2002).
75. B. Eibl, S. Ebner, C. Duba, G. Bock, N. Romani, M. Erdel, A. Gachter, D. Niederwieser and G. Schuler. Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response. Genes Chromosomes Cancer 20(3):215-223 (1997).
76. A. Choudhury, A. Toubert, S. Sutaria, D. Charron, R.E. Champlin and D.F. Claxton. Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity. Crit Rev Immunol 18(1-2):121-131 (1998).
77. F. Santiago-Schwarz, D.L. Coppock, A.A. Hindenburg and J. Kern. Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood 84(9):3054-3062 (1994).
78. C. Wang, H.M. Al-Omar, L. Radvanyi, A. Banerjee, D. Bouman, J. Squire and H.A. Messner. Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha. Exp Hematol 27(7):1176-1184 (1999).
79. A. Cignetti, A. Vallario, I. Roato, P. Circosta, B. Allione, L. Casorzo, P. Ghia and F. Caligaris-Cappio. Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses. J Immunol 173(4):2855-2865 (2004).
80. Y. Laouar, T. Welte, X.Y. Fu and R.A. Flavell. STAT3 is required for Flt3L-dependent dendritic cell differentiation. Immunity 19(6):903-912 (2003).
81. L. Wu, A. Nichogiannopoulou, K. Shortman and K. Georgopoulos. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 7(4):483-492 (1997).
82. Y. Laouar, I.N. Crispe and R.A. Flavell. Overexpression of IL-7R alpha provides a competitive advantage during early T-cell development. Blood 103(6):1985-1994 (2004).
83. R. Schotte, M.C. Rissoan, N. Bendriss-Vermare, J.M. Bridon, T. Duhen, K. Weijer, F. Briere and H. Spits. The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development. Blood 101(3):1015-1023 (2003).
84. Y. Takai, A. Kishimoto, Y. Iwasa, Y. Kawahara, T. Mori and Y. Nishizuka. Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids. J Biol Chem 254(10):3692-3695 (1979).
85. Y. Takai, A. Kishimoto, U. Kikkawa, T. Mori and Y. Nishizuka. Unsaturated diacylglycerol as a possible messenger for the activation of calcium-activated, phospholipid-dependent protein kinase system. Biochem Biophys Res Commun 91(4):1218-1224 (1979).
86. M. Castagna, Y. Takai, K. Kaibuchi, K. Sano, U. Kikkawa and Y. Nishizuka. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 257(13):7847-7851 (1982).
87. A.S. Kraft and W.B. Anderson. Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane. Nature 301(5901):621-623 (1983).
88. M. Spitaler and D.A. Cantrell. Protein kinase C and beyond. Nat Immunol 5(8):785-790 (2004).
89. W.S. Liu and C.A. Heckman. The sevenfold way of PKC regulation. Cell Signal 10(8):529-542 (1998).
90. D. Schechtman and D. Mochly-Rosen. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene 20(44):6339-6347 (2001).
91. J.C. Yan, Z.G. Wu, X.T. Kong, R.Q. Zong and L.Z. Zhang. Effect of CD40-CD40 ligand interaction on diacylglycerol-protein kinase C signal transduction pathway and intracellular calcium in cultured human monocytes. Acta Pharmacol Sin 24(7):687-691 (2003).
92. N. Geijsen, M. Spaargaren, J.A. Raaijmakers, J.W. Lammers, L. Koenderman and P.J. Coffer, Association of RACK1 and PKCbeta with the common beta-chain of the IL-5/IL-3/GM-CSF receptor. Oncogene 18(36):5126-5130 (1999).
93. A.L. Goodell, H.S. Oh, S.A. Meyer and R.C. Smart. Epidermal protein kinase C-beta 2 is highly sensitive to downregulation and is exclusively expressed in Langerhans cells: downregulation is associated with attenuated contact hypersensitivity. J Invest Dermatol 107(3):354-359 (1996).
94. P.J. Cejas, L.M. Carlson, J. Zhang, S. Padmanabhan, D. Kolonias, I. Lindner, S. Haley, L.H. Boise and K.P. Lee. Protein kinase C betaII plays an essential role in dendritic cell differentiation and autoregulates its own expression. J Biol Chem 280(31):28412-28423 (2005).
95. G. Ramadan, R.E. Schmidt and J. Schubert. In vitro generation of human CD86+ dendritic cells from CD34+ haematopoietic progenitors by PMA and in serum-free medium. Clin Exp Immunol 125(2):237-244 (2001).
96. I. Lindner, M.A. Kharfan-Dabaja, E. Ayala, D. Kolonias, L.M. Carlson, Y. Beazer-Barclay, U. Scherf, J.H. Hnatyszyn and K.P. Lee, Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL. J Immunol 171(4):1780-1791 (2003).
97. M. Kharfan-Dabaja, E. Ayala, I. Lindner, P.J. Cejas, N.J. Bahlis, D. Kolonias, L.M. Carlson and K.P. Lee. Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals. Cancer Immunol Immunother 54(1):25-36 (2005).
98. P.J. Cejas, L.M. Carlson, D. Kolonias, J. Zhang, I. Lindner, D.D. Billadeau, L.H. Boise and K.P. Lee. Regulation of RelB expression during the initiation of dendritic cell differentiation. Mol Cell Biol 25(17):7900-7916 (2005).
99. A. Cariappa, L. Chen, K. Haider, M. Tang, E. Nebelitskiy, S.T. Moran and S. Pillai. A catalytically inactive form of protein kinase C-associated kinase/receptor interacting protein 4, a protein kinase C beta-associated kinase that mediates NF-kappa B activation, interferes with early B cell development. J Immunol 171(4):1875-1880 (2003).
100. A.K. Olsson, K. Vadhammar and E. Nanberg. Activation and protein kinase C-dependent nuclear accumulation of ERK in differentiating human neuroblastoma cells. Exp Cell Res 256(2):454-467 (2000).
101. T.T. Su, B. Guo, Y. Kawakami, K. Sommer, K. Chae, L.A. Humphries, R.M. Kato, S. Kang, L. Patrone, R. Wall, M. Teitell, M. Leitges, T. Kawakami and D.J. Rawlings. PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol 3(8):780-786 (2002).
102. A. Kumar, T.C. Chambers, B.A. Cloud-Heflin and K.D. Mehta. Phorbol ester-induced low density lipoprotein receptor gene expression in HepG2 cells involves protein kinase C-mediated p42/44 MAP kinase activation. J Lipid Res 38(11):2240-2248 (1997).
103. J. Xie, Y. Wang, M.E. Freeman 3rd, B. Barlogie and Q. Yi. Beta 2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells. Blood 101(10):4005-4012 (2003).
104. L. Wu, A. D'Amico, K.D. Winkel, M. Suter, D. Lo and K. Shortman. RelB is essential for the development of myeloid-related CD8alpha- dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity 9(6):839-847 (1998).
105. J. Xie, J. Qian, S. Wang, M.E. Freeman 3rd, J. Epstein and Q. Yi. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38. J Immunol 171(9):4792-4800 (2003).
106. J. Xie, J. Qian, J. Yang, S. Wang, M.E. Freeman 3rd and Q. Yi. Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells. Exp Hematol 33(5):564-572 (2005).
107. W. Lim, W. Ma, K. Gee, S. Aucoin, D. Nandan, F. Diaz-Mitoma, M. Kozlowski and A. Kumar. Distinct role of p38 and c-Jun N-terminal kinases in IL-10-dependent and IL-10-independent regulation of the costimulatory molecule B7.2 in lipopolysaccharide-stimulated human monocytic cells. J Immunol 168(4):1759-1769 (2002).
108. K. Sato, H. Nagayama, K. Tadokoro, T. Juji and T.A. Takahashi. Extracellular signal-regulated kinase, stress-activated protein kinase/c-Jun N-terminal kinase, and p38mapk are involved in IL-10-mediated selective repression of TNF-alpha-induced activation and maturation of human peripheral blood monocyte-derived dendritic cells. J Immunol 162(7):3865-3872 (1999).
109. J.F. Arrighi, M. Rebsamen, F. Rousset, V. Kindler and C. Hauser. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol 166(6):3837-3845 (2001).
110. A. Puig-Kroger, M. Relloso, O. Fernandez-Capetillo, A. Zubiaga, A. Silva, C. Bernabeu and A.L. Corbi. Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells. Blood 98(7):2175-2182 (2001).
111. A. Puig-Kroger, F. Sanz-Rodriguez, N. Longo, P. Sanchez-Mateos, L. Botella, J. Teixido, C. Bernabeu and A.L. Corbi. Maturation-dependent expression and function of the CD49d integrin on monocyte-derived human dendritic cells. J Immunol 165(8):4338-4345 (2000).
112. Y. Yanagawa, N. Iijima, K. Iwabuchi and K. Onoe. Activation of extracellular signal-related kinase by TNF-alpha controls the maturation and function of murine dendritic cells. J Leukoc Biol 71(1):125-132 (2002).
113. M. Rescigno, M. Martino, C.L. Sutherland, M.R. Gold and P. Ricciardi-Castagnoli. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med 188(11):2175-2180 (1998).
114. S. Yoshimura, J. Bondeson, F.M. Brennan, B.M. Foxwell and M. Feldmann. Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur J Immunol 31(6):1883-1893 (2001).
115. S. Yoshimura, J. Bondeson, B.M. Foxwell, F.M. Brennan and M. Feldmann. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int Immunol 13(5):675-683 (2001).
116. F. Ouaaz, J. Arron, Y. Zheng, Y. Choi and A.A. Beg. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 16(2):257-270 (2002).
117. A.R. Pettit, K.P. MacDonald, B. O'Sullivan and R. Thomas. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthr Rheum 43(4):791-800 (2000).
118. P.A. Baeuerle and T. Henkel. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12(141-1790 (1994).
119. S. Ghosh, M.J. May and E.B. Kopp. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16:225-260 (1998).
120. F.G. Wulczyn, D. Krappmann and C. Scheidereit. The NF-kappa B/Rel and I kappa B gene families: mediators of immune response and inflammation. J Mol Med 74(12):749-769 (1996).
121. S. Yoshimura, J. Bondeson, B.M. Foxwell, F.M. Brennan and M. Feldmann. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int Immunol 13(5):675-683 (2001).
122. F. Ouaaz, J. Arron, Y. Zheng, Y. Choi and A.A. Beg. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 16(2):257-270 (2002).
123. D.S. Weih, Z.B. Yilmaz and F. Weih. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol 167(4):1909-1919 (2001).
124. R. Valero, M.L. Baron, S. Guerin, S. Beliard, H. Lelouard, B. Kahn-Perles, B. Vialettes, C. Nguyen, J. Imbert and P. Naquet. A defective NF-kappa B/RelB pathway in autoimmune-prone New Zealand black mice is associated with inefficient expansion of thymocyte and dendritic cells. J Immunol 169(1):185-192 (2002).
125. B.J. O'Sullivan, K.P. MacDonald, A.R. Pettit and R. Thomas. RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. Proc Natl Acad Sci USA 97(21):11421-11426 (2000).
126. G.J. Clark, S. Gunningham, A. Troy, S. Vuckovic and D.N. Hart. Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology 98(2):189-196 (1999).
127. F. Weih, G. Warr, H. Yang and R. Bravo. Multifocal defects in immune responses in RelB-deficient mice. J Immunol 158(11):5211-5218 (1997).
128. M. Neumann, H. Fries, C. Scheicher, P. Keikavoussi, A. Kolb-Maurer, E. Brocker, E. Serfling and E. Kampgen. Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 95(1):277-285 (2000).
129. D. Carrasco, R.P. Ryseck and R. Bravo. Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 118(4):1221-1231 (1993).
130. A.R. Pettit, K.P. MacDonald, B. O'Sullivan and R. Thomas. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthr Rheum 43(4):791-800 (2000).
131. B. Platzer, A. Jorgl, S. Taschner, B. Hocher and H. Strobl. RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 104(12):3655-3663 (2004).
132. R.P. Ryseck, P. Bull, M. Takamiya, V. Bours, U. Siebenlist, P. Dobrzanski and R. Bravo. RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. Mol Cell Biol 12(2):674-684 (1992).
133. P. Dobrzanski, R.P. Ryseck and R. Bravo. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. Oncogene 10(5):1003-1007 (1995).
134. N.J. Solan, H. Miyoshi, E.M. Carmona, G.D. Bren and C.V. Paya. RelB cellular regulation and transcriptional activity are regulated by p100. J Biol Chem 277(2):1405-1418 (2002).
135. K. Speirs, L. Lieberman, J. Caamano, C.A. Hunter and P. Scott. Cutting edge: NF-kappa B2 is a negative regulator of dendritic cell function. J Immunol 172(2):752-756 (2004).
136. G. Bonizzi and M. Karin. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25(6):280-288 (2004).
137. G. Xiao, E.W. Harhaj and S.C. Sun. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol Cell 7(2):401-409 (2001).
138. M. Karin and Y. Ben-Neriah. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18:621-663 (2000).
139. L. Lin, G.N. DeMartino and W.C. Greene. Cotranslational biogenesis of NF-kappaB p50 by the 26S proteasome. Cell 92(6):819-828 (1998).
140. T. Lernbecher, B. Kistler and T. Wirth. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. Embo J 13(17):4060-4069 (1994).
141. D.A. Francis, R. Sen, N. Rice and T.L. Rothstein. Receptor-specific induction of NF-kappaB components in primary B cells. Int Immunol 10(3):285-293 (1998).
142. B. Kistler, A. Rolink, R. Marienfeld, M. Neumann and T. Wirth. Induction of nuclear factor-kappa B during primary B cell differentiation. J Immunol 160(5):2308-2317 (1998).
143. M. Suhasini, C.D. Reddy, E.P. Reddy, J.A. DiDonato and R.B. Pilz. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation. Oncogene 15(15):1859-1870 (1997).
144. F. Rossi, M. McNagny, G. Smith, J. Frampton and T. Graf. Lineage commitment of transformed haematopoietic progenitors is determined by the level of PKC activity. Embo J 15(8):1894-1901 (1996).
145. S. Glennie, I. Soeiro, P.J. Dyson, E.W. Lam and F. Dazzi. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105(7):2821-2827 (2005).
146. B. Verdoodt, T. Blazek, P. Rauch, G. Schuler, A. Steinkasserer, M.B. Lutz and J.O. Funk. The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy. Eur J Immunol 33(11):3154-3163 (2003).
147. A.D. Wells, M.C. Walsh, J.A. Bluestone and L.A. Turka. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest 108(6):895-903 (2001).
148. J. Sun, M. Alison Stalls, K.L. Thompson and N. Fisher Van Houten. Cell cycle block in anergic T cells during tolerance induction. Cell Immunol 225(1):33-41 (2003).
149. D.I. Gabrilovich, H.L. Chen, K.R. Girgis, H.T. Cunningham, G.M. Meny, S. Nadaf, D. Kavanaugh and D.P. Carbone. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2(10):1096-1103 (1996).
150. T. Oyama, S. Ran, T. Ishida, S. Nadaf, L. Kerr, D.P. Carbone and D.I. Gabrilovich. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol 160(3):1224-1232 (1998).
151. N. Boissel, P. Rousselot, E. Raffoux, J.M. Cayuela, O. Maarek, D. Charron, L. Degos, H. Dombret, A. Toubert and D. Rea. Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylate. Leukemia 18(10):1656-1661 (2004).
152. A. Agrawal, J. Lingappa, S.H. Leppla, S. Agrawal, A. Jabbar, C. Quinn and
153. S. Mahanty, K. Hutchinson, S. Agarwal, M. McRae, P.E. Rollin and B. Pulendran. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol 170(6):2797-2801 (2003).
154. G. Denecker, W. Declercq, C.A. Geuijen, A. Boland, R. Benabdillah, M. van Gurp, M.P. Sory, P. Vandenabeele and G.R. Cornelis. Yersinia enterocolitica YopP-induced apoptosis of macrophages involves the apoptotic signaling cascade upstream of bid. J Biol Chem 276(23):19706-19714 (2001).
155. C.J. Hueck. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62(2):379-433 (1998).
156. L.E. Palmer, A.R. Pancetti, S. Greenberg and J.B. Bliska. YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells. Infect Immun 67(2):708-716 (1999).
157. I. Sorg, U.M. Goehring, K. Aktories and G. Schmidt. Recombinant Yersinia YopT leads to uncoupling of RhoA-effector interaction. Infect Immun 69(12):7535-7543 (2001).
158. M. Iriarte and G.R. Cornelis. YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells. Mol Microbiol 29(3):915-929 (1998).
159. R. Rosqvist, A. Forsberg and H. Wolf-Watz. Intracellular targeting of the Yersinia YopE cytotoxin in mammalian cells induces actin microfilament disruption. Infect Immun 59(12):4562-4569 (1991).
160. K. Schesser, A.K. Spiik, J.M. Dukuzumuremyi, M.F. Neurath, S. Pettersson and H. Wolf-Watz. The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity. Mol Microbiol 28(6):1067-1079 (1998).
161. G.R. Cornelis, A. Boland, A.P. Boyd, C. Geuijen, M. Iriarte, C. Neyt, M.P. Sory and I. Stainier. The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 62(4):1315-1352 (1998).
162. M. Aepfelbacher, R. Zumbihl, K. Ruckdeschel, C.A. Jacobi, C. Barz and J. Heesemann. The tranquilizing injection of Yersinia proteins: a pathogen's strategy to resist host defense. Biol Chem 380(7-8):795-802 (1999).
163. K. Ruckdeschel, S. Harb, A. Roggenkamp, M. Hornef, R. Zumbihl, S. Kohler, J. Heesemann and B. Rouot. Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production. J Exp Med 187(7):1069-1079 (1998).
164. K. Orth, Z. Xu, M.B. Mudgett, Z.Q. Bao, L.E. Palmer, J.B. Bliska, W.F. Mangel, B. Staskawicz and J.E. Dixon. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 290(5496):1594-1597 (2000).
165. K. Orth, L.E. Palmer, Z.Q. Bao, S. Stewart, A.E. Rudolph, J.B. Bliska and J.E. Dixon. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 285(5435):1920-1923 (1999).
166. S.E. Erfurth, S. Grobner, U. Kramer, D.S. Gunst, I. Soldanova, M. Schaller, I.B. Autenrieth and S. Borgmann. Yersinia enterocolitica induces apoptosis and inhibits surface molecule expression and cytokine production in murine dendritic cells. Infect Immun 72(12):7045-7054 (2004).
167. M. Schoppet, A. Bubert and H.I. Huppertz. Dendritic cell function is perturbed by Yersinia enterocolitica infection in vitro. Clin Exp Immunol 122(3):316-323 (2000).
168. K. Trulzsch, G. Geginat, T. Sporleder, K. Ruckdeschel, R. Hoffmann, J. Heesemann and H. Russmann. Yersinia outer protein P inhibits CD8 T cell priming in the mouse infection model. J Immunol 174(7):4244-4251 (2005).
169. M.M. Marketon, R.W. Depaolo, K.L. Debord, B. Jabri and O. Schneewind. Plague bacteria target immune cells during infection. Science 309(5741):1739-1741 (2005).
170. B.A. Chromy:J. Perkins, J.L. Heidbrink, A.D. Gonzales, G.A. Murphy, J.P. Fitch and S.L. McCutchen-Maloney. Proteomic characterization of host response to Yersinia pestis and near neighbors. Biochem Biophys Res Commun 320(2):474-479 (2004).